December 11, 2023
Ultragenyx Pharmaceutical’s evinacumab and Alexion Pharmaceuticals’ danicopan cleared the review of a Japanese advisory panel on December 8, putting them in line for regulatory approval shortly along with a batch of other medicines endorsed on the day. The Pharmaceutical Affairs...read more